Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1999 1
2003 1
2004 1
2008 1
2011 1
2012 2
2013 3
2014 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Familial focal alopecia"
Page 1
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
Sterkens A, Lambert J, Bervoets A. Sterkens A, et al. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. Clin Exp Med. 2021. PMID: 33386567 Review.
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebrows, or even the entire body. ...In many cases, treated or non-treated, relapse often occurs. The prognosis is uncertain and is negat …
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebr …
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL, Luk DCK, Leung AKC, Ng C, Loo SKF. Hon KL, et al. Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):117-132. doi: 10.2174/1872213X14999200728145822. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 32723274 Review.
BACKGROUND: Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood. OBJECTIVE: This article aims to review genetics, therapy, prognosis, and recent patents for AA. METHODS: We used clinical queries and keywords "alopecia area …
BACKGROUND: Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood. OBJECTIVE: This article aims to …
Variant PADI3 in Central Centrifugal Cicatricial Alopecia.
Malki L, Sarig O, Romano MT, Méchin MC, Peled A, Pavlovsky M, Warshauer E, Samuelov L, Uwakwe L, Briskin V, Mohamad J, Gat A, Isakov O, Rabinowitz T, Shomron N, Adir N, Simon M, McMichael A, Dlova NC, Betz RC, Sprecher E. Malki L, et al. N Engl J Med. 2019 Feb 28;380(9):833-841. doi: 10.1056/NEJMoa1816614. Epub 2019 Feb 13. N Engl J Med. 2019. PMID: 30763140
BACKGROUND: Central centrifugal cicatricial alopecia (CCCA) is the most common form of scarring alopecia among women of African ancestry. The disease is occasionally observed to affect women in families in a manner that suggests an autosomal dominant trait an …
BACKGROUND: Central centrifugal cicatricial alopecia (CCCA) is the most common form of scarring alopecia among women of Africa …
An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
Brown L, Skopit S. Brown L, et al. J Drugs Dermatol. 2018 Aug 1;17(8):914-917. J Drugs Dermatol. 2018. PMID: 30124734 Review.
Patient followed up two months later with worsening of his alopecia at a rapid pace, presenting now with hair loss of the entire scalp and loss of the eyebrows. He was diagnosed with progression to alopecia universalis at that time, with a corresponding SALT (Severi …
Patient followed up two months later with worsening of his alopecia at a rapid pace, presenting now with hair loss of the entire scal …
Profile of vitiligo in the south of Tunisia.
Akrem J, Baroudi A, Aichi T, Houch F, Hamdaoui MH. Akrem J, et al. Int J Dermatol. 2008 Jul;47(7):670-4. doi: 10.1111/j.1365-4632.2008.03695.x. Int J Dermatol. 2008. PMID: 18613871
The most common clinical pattern observed was vitiligo vulgaris, followed by focal, acrofacial, mucosal, segmental, and universal types. Leukotrichia was observed in 23%, koebnerization in 18.5%, and a positive family history in 18%. ...There were associated endocri …
The most common clinical pattern observed was vitiligo vulgaris, followed by focal, acrofacial, mucosal, segmental, and universal typ …
Successful treatment of alopecia areata with Dr. Michaels (Alopinex) product family.
Wollina U, Hercogovấ J, Fioranelli M, Gianfaldoni S, Chokoeva AA, Tchernev G, Tirant M, Novotny F, Roccia MG, Maximov GK, França K, Lotti T. Wollina U, et al. J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2 Suppl 3):83-7. J Biol Regul Homeost Agents. 2016. PMID: 27498663 Clinical Trial.
The aim of this study was to evaluate the efficacy and tolerability of complementary medicine, Dr. Michaels product family, in the treatment of alopecia areata. MATERIALS AND METHODS: 40 patients (27 female/13 male), with a mean age of 20.3 years, all of them with 1 …
The aim of this study was to evaluate the efficacy and tolerability of complementary medicine, Dr. Michaels product family, in the tr …
Vitiligo: clinical findings in 1436 patients.
Handa S, Kaur I. Handa S, et al. J Dermatol. 1999 Oct;26(10):653-7. doi: 10.1111/j.1346-8138.1999.tb02067.x. J Dermatol. 1999. PMID: 10554431
Vitiligo vulgaris was the commonest form of the disease in 1002 (69.8%) patients followed by focal vitiligo in 214 (14.9%) and segmental vitiligo in 72 (5.0%). ...Of the various diseases associated with vitiligo, atopic/nummular eczema was seen in 20 (1.4%) patients, bronc …
Vitiligo vulgaris was the commonest form of the disease in 1002 (69.8%) patients followed by focal vitiligo in 214 (14.9%) and segmen …
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase trial.
Pérez-García JM, Llombart-Cussac A, G Cortés M, Curigliano G, López-Miranda E, Alonso JL, Bermejo B, Calvo L, Carañana V, de la Cruz Sánchez S, M Vázquez R, Prat A, R Borrego M, Sampayo-Cordero M, Seguí-Palmer MÁ, Soberino J, Malfettone A, Schmid P, Cortés J. Pérez-García JM, et al. Eur J Cancer. 2021 May;148:382-394. doi: 10.1016/j.ejca.2021.02.028. Epub 2021 Mar 29. Eur J Cancer. 2021. PMID: 33794440 Clinical Trial.
METHODS: This single-arm, phase trial enrolled women aged 18 years with HR+, HER2-negative, inoperable, locally recurrent or metastatic BC. Patients were previously treated with hormonal therapy and 1-2 chemotherapy regimens for locally recurrent and/or metastatic B …
METHODS: This single-arm, phase trial enrolled women aged 18 years with HR+, HER2-negative, inoperable, locally recurrent or metastat …
Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata.
Ganjoo S, Thappa DM. Ganjoo S, et al. Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):408-17. doi: 10.4103/0378-6323.110767. Indian J Dermatol Venereol Leprol. 2013. PMID: 23619446 Free article. Clinical Trial.

Late and incomplete responders showed statistically significant association with family history of alopecia areata (p < 0.0001), presence of recurrent disease (p = 0.0147) and presence of nail changes (p = 0.0007). ...CONCLUSION: Intralesional triamcinolone aceto

Late and incomplete responders showed statistically significant association with family history of alopecia areata (p < 0.0

Childhood vitiligo: clinicoepidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India.
Agarwal S, Gupta S, Ojha A, Sinha R. Agarwal S, et al. Pediatr Dermatol. 2013 May-Jun;30(3):348-53. doi: 10.1111/pde.12032. Epub 2012 Dec 26. Pediatr Dermatol. 2013. PMID: 23278409

On comparison of childhood- and later-onset vitiligo, there were statistically significant differences (p < 0.05) in sex, family history, type of vitiligo (segmental and vulgaris), and site of onset. ...Childhood-onset vitilgo differs from later-onset vitiligo in many c

On comparison of childhood- and later-onset vitiligo, there were statistically significant differences (p < 0.05) in sex, family h

18 results